MedPath

Effect of Ursolic Acid of Loquat Extract on Function of Muscle

Phase 2
Completed
Conditions
Sarcopenia
Registration Number
NCT02401113
Lead Sponsor
Pusan National University Hospital
Brief Summary

This randomized, placebo-controlled, double-blind study was designed to investigate the efficacy and tolerability of Ursolic Acid of Loquat Extract for treatment of muscle function improvement with relatively health adults. 54 subjects received 500 mg of Loquat Extract per day or a placebo for 12 weeks.

Detailed Description

This randomized, placebo-controlled, double-blind study was designed to investigate the efficacy and tolerability of Ursolic Acid of Loquat Extract for treatment of muscle function improvement with relatively health adults. 54 subjects received 500 mg of Loquat Extract per day or a placebo for 12 weeks. Change over time in muscle fuction was evaluated by four outcomes: assessment of appendicular skeletal mass using DEXA (dual energy X-ray absorptiometry); quadriceps muscle power by Biodex; hand grib power; and Short Physical Performance Battery, SPPB.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • BMI 18.5-30KG/M2
Exclusion Criteria
  • > SERUM creatinine 1.2mg/dL
  • > AST or ALT 60IU/L
  • DM Patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
quadriceps muscle function12weeks
Secondary Outcome Measures
NameTimeMethod
ASM(appendicular skeletal mass) marker12weeks
Short Physical Performance Battery, SPPB12weeks

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.